Skip to main content
Article thumbnail
Location of Repository

Assessment of Phytochemicals in Preventing Oxidatively Damaged DNA in Bladder Cancer

By Murizal Zainol


Oxidatively damaged DNA is thought to be important in both the initiation and development of bladder carcinoma. Phytochemical compounds are thought to promote optimal health, partly via their antioxidant effects in protecting cellular components against damaging free radicals. The objective of this study is to assess the effect of a standardised bilberry extract, mirtoselect, on the level of endogenous and induced oxidatively damaged DNA in bladder cancer cells, as assessed by the Comet assay. The Comet assay, also known as single-cell gel electrophoresis, represents a simple method for measuring DNA strand break damage in eukaryotic cells. The sensitivity and specificity of the assay is greatly enhanced by the addition of bacterial repair endonucleases that recognise specific types of damage in the DNA and converts these lesions into additional DNA breaks. -\ud Studies of mirtoselect against three bladder cancer cell lines (RT112, RT4 and HT1376) have shown significant antiproliferative activities against RT112 cells and against RT4 cells (p<0.05), but not against HT1376 cells. The treatment of all bladder cancer cell lines with mirtoselect (50 µg/ml) for a duration of seven days did not lower the level of endogenous oxidatively damaged DNA as detected by the modified endonuclease-alkaline Comet assay. However, a significant level of protection was observed when exogenous hydrogen peroxide was used to induce oxidatively damaged DNA in all the bladder cancer cell lines studied. Further studies revealed that mirtoselect may possibly mediate its antioxidant property through metal chelation, rather than free radical scavenging. -\ud Our studies demonstrated that mirtoselect was potent enough to reduce levels of exogenously-induced oxidatively damaged DNA in the bladder cancer cell lines studied. Additionally, the ability of mirtoselect to reduce bladder cancer cells proliferation further highlights anthocyanins as promising future chemopreventive agents against bladder cancer

Publisher: University of Leicester
Year: 2011
OAI identifier:

Suggested articles


  1. (1988). [Oxygen free radical production and DNA damage induced by metal compounds and hydrogen peroxide]. Tanpakushitsu Kakusan Koso
  2. (1986). [Prophylactic effect of etretinate on the recurrence of superficial bladder tumors--results of a randomized control study]. Hinyokika Kiyo
  3. (1992). 13-Cis-Retinoic Acid in Chemoprevention of Superficial BladderCancer.
  4. (1994). 2 Molecular Pathways to Transitional-Cell Carcinoma of the Bladder. Cancer Research
  5. (2007). 2-Arylidenedihydroindole-3-ones: design, synthesis, and biological activity on bladder carcinoma cell lines. Bioorg Med Chem Lett
  6. (1994). 7,8-Dihydro-8-Oxo-2'-Deoxyguanosine Present in DNA Is Not Simply an Artifact of Isolation. Carcinogenesis
  7. (1992). 8-Hydroxyguanine, an Abundant Form of Oxidative
  8. (2009). A comparative study of phenolic compounds and antioxidant and antiproliferative activities in frequently consumed raw vegetables.
  9. (1996). A quantum chemical explanation of the antioxidant activity of flavonoids.
  10. (1996). A quantum chemical explanation of the antioxidant activity of flavonoids. Chemical Research in Toxicology
  11. (1991). A rapid non-radioactive fluorescence assay for the measurement of both cell number and proliferation.
  12. (2002). A review of fluorescence methods for assessing labile iron in cells and biological fluids. Analytical Biochemistry
  13. (1988). A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res
  14. (1988). A Site-Specific Mechanism for Free-Radical Induced Biological Damage - the Essential Role of Redox-Active Transition-Metals. Free Radical Biology and Medicine
  15. (2001). Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Research
  16. (1997). Abnormal c-myc oncogene DNA methylation in human bladder cancer: Possible role in tumor progression. European Urology
  17. (2006). Acai (Euterpe oleracea mart.) polyphenolics in their glycoside and aglycone forms induce apoptosis of HL-60 leukemia cells.
  18. (1988). Activated neutrophils induce prolonged DNA damage in neighboring cells. Carcinogenesis
  19. Activation of peroxisome proliferator-activated receptor-gamma reverses squamous metaplasia and induces transitional differentiation in normal human urothelial cells.
  20. (1992). Activity of 4-Hpr in Superficial Bladder-Cancer Using DNA Flow-Cytometry as an Intermediate End-Point.
  21. (1995). Adjuvant treatment with a vitamin A analogue (etretinate) after transurethral resection of superficial bladder tumors. Final analysis of a prospective, randomized multicenter trial in Switzerland. Eur Urol
  22. (1996). An acid phosphatase assay for quantifying the growth of adherent and nonadherent cells. Analytical Biochemistry
  23. (2007). an anthocyanidin in pigmented fruits and vegetables, protects human HaCaT keratinocytes and mouse skin against UVB-mediated oxidative stress and apoptosis.
  24. (2010). An ECVAG trial on assessment of oxidative damage to DNA measured by the comet assay. Mutagenesis
  25. (1977). An intracellular transit iron pool. In: CIBA foundation symposium 51--Ruth
  26. (2005). An overview of chemosensitivity testing. Methods Mol Med
  27. (2003). Analysis and biological activities of anthocyanins. Phytochemistry
  28. (1994). Analysis of 4-aminobiphenyl-DNA adducts in human urinary bladder and lung by alkaline hydrolysis and negative ion gas chromatography-mass spectrometry. Environ Health Perspect
  29. (2004). and anti-carcinogenic properties of a novel anthocyanin-rich berry extract formula. Biochemistry-Moscow
  30. (1994). Annual Review of Biochemistry
  31. (2002). Anthocyanin and antioxidant capacity in Roselle (Hibiscus sabdariffa L.) extract. Food Research International
  32. (2007). Anthocyanin fraction from potato extracts is cytotoxic to prostate cancer cells through activation of caspasedependent and caspase-independent pathways. Carcinogenesis
  33. (2003). Anthocyanin-rich extract from Aronia meloncarpa E. induces a cell cycle block in colon cancer but not normal colonic cells. Nutrition and Cancer-an International Journal
  34. (2007). Anthocyanin-rich grape extract blocks breast cell DNA damage.
  35. (2010). Anthocyanin-rich red grape extract impedes adenoma development in the Apc(Min) mouse: Pharmacodynamic changes and anthocyanin levels in the murine biophase.
  36. (2008). Anthocyanin/Polyphenolic-Rich Fruit Juice Reduces Oxidative Cell Damage in an Intervention Study with Patients on Hemodialysis. Cancer Epidemiology Biomarkers & Prevention
  37. (2008). Anthocyanins and their role in cancer prevention. Cancer Letters
  38. (2001). Anthocyanins are absorbed in glycated forms in elderly women: a pharmacokinetic study.
  39. (1999). Anthocyanins are detected in human plasma after oral administration of an elderberry extract. Clin Chem
  40. (1999). Anthocyanins are potent antioxidants in model systems but do not reduce endogeneous oxidative DNA damage in human colon cells.
  41. (2009). Anthocyanins from black soybean seed coats stimulate wound healing in fibroblasts and keratinocytes and prevent inflammation in endothelial cells. Food and Chemical Toxicology
  42. (2006). Anthocyanins in Cornus alternifolia, and Cornus controversa, Cornus kousa and Cornus florida fruits with health benefits. Life Sciences
  43. (1993). Anthocyanins in fruits, vegetables and grains.
  44. (2004). Anthocyanins induce cell cycle perturbations and apoptosis in different human cell lines. Carcinogenesis
  45. (2003). Anthocyanins protect against DNA damage induced by tert-butyl-hydroperoxide in rat smooth muscle and hepatoma cells. Mutation Research
  46. (2004). anthocyanins, ascorbic acid, and radical scavenging activity of Rubus, Ribes, and Aronia.
  47. (1998). Antimutagenic role of base-excision repair enzymes upon free radical-induced DNA damage. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis
  48. (2006). Antioxedant flavonol glycosedes from Dorycnium hirsutum.
  49. (2007). Antioxidant activities of different colored sweet bell peppers (Capsicum annuum L.). J Food Sci
  50. (2002). Antioxidant activity and phenolic content of oregon caneberries.
  51. (2005). Antioxidant activity of anthocyanin glycoside derivatives evaluated by the inhibition of liposome oxidation.
  52. Antioxidant activity of anthocyanins and their aglycons.
  53. (2000). Antioxidant activity of nasunin, an anthocyanin in eggplant peels. Toxicology
  54. (2002). Antioxidant and anti proliferative activities of common fruits.
  55. Antioxidant and anti proliferative activities of raspberries.
  56. (2002). Antioxidant and antiproliferative activities of common vegetables. J Agric Food Chem
  57. (2003). Antioxidant and antiproliferative activities of strawberries.
  58. (2001). Antioxidant and antiradical activities of flavonoids.
  59. (1997). Antioxidant and prooxidant behavior of flavonoids: Structureactivity relationships. Free Radical Biology and Medicine
  60. (2003). Antioxidant effects of tea: evidence from human clinical trials.
  61. (1997). Antioxidant properties of phenolic compounds. Trends in Plant Science
  62. (2004). Antioxidants and radiation therapy.
  63. (1999). Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med
  64. (2010). Antiproliferative and antioxidant properties of anthocyanin-rich extract from acai. Food Chemistry
  65. (1976). Approaches to Prevention of Epithelial Cancer during Preneoplastic Period. Cancer Research
  66. (2008). Assessing oxidative DNA damage in bladder cancer cells using the modified alkaline Comet assay. Poster at the NCRI Cancer Conference, International Convention Centre,
  67. (2010). Assessment and reduction of comet assay variation in relation to DNA damage: studies from the European Comet Assay Validation Group. Mutagenesis
  68. (2003). Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils.
  69. Berries and Fruits in chemoprevention. In:
  70. (2007). Berry anthocyanins as novel antioxidants in human health and disease prevention. Molecular Nutrition & Food Research
  71. (2008). Berry extracts exert different antiproliferative effects against cervical and colon cancer cells grown in vitro.
  72. (2001). Berry phenolics and their antioxidant activity.
  73. (2007). Berry phytochemicals, genomic stability and cancer: evidence for chemoprotection at several stages in the carcinogenic process. Mol Nutr Food Res
  74. (2003). beta-Thalassaemia: emergence of new and improved iron chelators for treatment.
  75. Biochemical and molecular bladder carcinogenesis. In: Comprehensive textbook of genitourinary oncology--Vogelzang
  76. (1995). Bioenergetic and Oxidative Stress in Neurodegenerative Diseases. Life Sciences
  77. (2005). Biomarker profiling for cancer diagnosis, prognosis and therapeutic management.
  78. (2006). black raspberry, blueberry, cranberry, red raspberry, and strawberry extracts inhibit growth and stimulate apoptosis of human cancer cells in vitro.
  79. (1971). Bladder Cancer Due to Exposure to Para-Aminobiphenyl -17-Year Followup.
  80. (1988). Bladder cancer in relation to cigarette smoking. Cancer Res
  81. (2005). Bladder cancer: Epidemiology, staging and grading, and diagnosis. Urology
  82. (2002). Bladder cancer. Surgery (Oxford)
  83. (1982). Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator.
  84. (1991). Cancer Causes Control
  85. (2008). Cancer statistics,
  86. (2000). Cancer-an International Journal
  87. (2004). Cancers of the bladder. Journal of the Royal Society for the Promotion of Health
  88. (2006). Catheter-associated urinary tract infection in primary and community health care. Age and Ageing
  89. (1998). Cell cycle targets of Ras/Raf signalling. Oncogene
  90. (1995). Cellular injury induced by oxidative stress is mediated through lysosomal damage. Free Radic Biol Med
  91. (2003). Cellular responses to H(2)O(2) and bleomycin-induced oxidative stress in L6C5 rat myoblasts. Free Radic Biol Med
  92. (2003). Changes in expression and activity of glutathione S-transferase in different organs of schistosoma haematobium-infected hamster. J Biochem Mol Toxicol
  93. (1968). Chemical analysis of DNA alterations. I. Base liberation and backbone breakage of DNA and oligodeoxyadenylic acid induced by hydrogen peroxide and hydroxylamine. Biochim Biophys Acta
  94. (2006). Chemical compositions, antioxidant capacities, and antiproliferative activities of selected fruit seed flours.
  95. (2004). Chemoprevention by Fruit Phenolic Compound. In: Cancer Chemoprevention: Promising Cancer Chemoprevention Agents--Kelloff
  96. (2009). Chemoprevention of Anthocyanins on Bladder Cancer Cells. Presentation at the 32nd Annual Meeting of UKEMS,
  97. (2008). Chemoprevention of bladder cancer.
  98. (2006). Chemoprevention of bladder cancer. Urology
  99. (2004). Chemoprevention of Cancer. Ca
  100. (2001). Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries. Cancer Research
  101. (2002). Chemoprevention of superficial bladder cancer. Critical Reviews in Oncology Hematology
  102. (1994). Chromosomal Instability, and Cancer - the Schistosomiasis Model. Cancer Research
  103. (1994). Chronic Infections and Inflammatory Processes as Cancer Risk-Factors - Possible Role of Nitric-Oxide in Carcinogenesis. Mutation Research
  104. (1994). Clinical Utility of the Immunocytochemical Detection of P53 Protein in Cytological Specimens. Cancer Research
  105. Combined analysis: a way to go? Urol Oncol (2000b) 5:204-210. Schulte
  106. (2001). Comet assay and early apoptosis. Mutat Res
  107. (2000). Comparison of biological effects of DNA damage induced by ionizing radiation and hydrogen peroxide in CHO cells.
  108. (1995). Comparison of Effects of Iron and Calcium Chelators on the Response of L5178y Sublines to X-Rays and H2o2. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis
  109. (1977). Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer. Urology
  110. (2006). Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption.
  111. (2009). Creating context for the use of DNA adduct data in cancer risk assessment: II. Overview of methods of identification and quantitation of DNA damage. Critical Reviews in Toxicology
  112. (1994). Culture of Animal Cells: A Manual of Basic Technique.
  113. (2007). Cyanidin-3-rutinoside, a natural polyphenol antioxidant, selectively kills leukemic cells by induction of oxidative stress.
  114. (1996). Cyclophosphamide associated bladder cancer - A highly aggressive disease: Analysis of 12 cases.
  115. (1996). Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis. Ann Intern Med
  116. (2009). Cystatin B As a Tissue and Urinary Biomarker of Bladder Cancer Recurrence and Disease Progression. Clinical Cancer Research
  117. (1996). Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer.
  118. (2002). de Bruijn EA. Oxidative DNA damage: biological significance and methods of analysis. Crit Rev Clin Lab Sci
  119. (1997). Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria. Febs Letters
  120. (2004). Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel. Clinical Cancer Research
  121. (2004). Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients. Clinical Cancer Research
  122. (1999). Determination of the Chelatable Iron Pool of Isolated Rat Hepatocytes by Digital Fluorescence Microscopy Using the Fluorescent Probe, Phen Green SK. Hepatology
  123. (1998). Development of an ultrasensitive in vitro assay to monitor growth of primary cell cultures with reduced mitotic activity.
  124. (2002). Dietary flavonoids: Bioavailability, metabolic effects, and safety. Annual Review of Nutrition
  125. (2008). Dietary polyphenols protect against Nnitrosamines and benzo(a)pyrene-induced DNA damage (strand breaks and oxidized purines/pyrimidines) in HepG2 human hepatoma cells.
  126. (2001). Differential staining of DNA strand breaks in dried comet assay slides. J Histochem Cytochem
  127. (1993). Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis
  128. (2006). Direct vasoactive and vasoprotective properties of anthocyanin-rich extracts.
  129. Distinct repair activities of human 7,8-dihydro-8 oxoguanine DNA glycosylase and formamidopyrimidine DNA glycosylase for formamidopyrimidine and 7,8-dihydro-8-oxoguanine.
  130. Distinct repair activities of human 7,8-dihydro-8-oxoguanine DNA glycosylase and formamidopyrimidine DNA glycosylase for formamidopyrimidine and 7,8-dihydro-8-oxoguanine.
  131. (1986). Distribution, and Function of Plant Flavonoids. In: Plant Flavonoids in Biology and Medicine--Cody
  132. (2010). DNA damage in earthworms from highly contaminated soils: Assessing resistance to arsenic toxicity by use of the Comet assay. Mutat Res
  133. (2001). DNA damage in human transitional cell carcinoma cells after exposure to the proximate metabolite of the bladder carcinogen 4-aminobiphenyl. Environmental and Molecular Mutagenesis
  134. (1988). DNA Damage Produced by Ionizing-Radiation in Mammalian-Cells - Identities, Mechanisms of Formation, and Reparability.
  135. (1995). DNA Strand Breakage Is Correlated with Unaltered Base Release after Gamma-Irradiation. Radiation Research
  136. (2009). Economic aspects of bladder cancer: what are the benefits and costs? World Journal of Urology
  137. (1989). Effect of Combinations of Antioxidants on Phagocyte-Induced Sister-Chromatid Exchanges. Mutation Research
  138. (2006). Effect of cyanidin-3-glucoside and an anthocyanin mixture from bilberry on adenoma development in the ApcMin mouse model of intestinal carcinogenesis--relationship with tissue anthocyanin levels.
  139. (1998). Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer.
  140. (2006). Effects of anthocyanins and other phenolics of boysenberry and blackcurrant as inhibitors of oxidative stress and damage to cellular DNA
  141. (2004). Effects of commercial anthocyaninrich extracts on colonic cancer and nontumorigenic colonic cell growth. J Agric Food Chem
  142. (2001). Effects of lyophilized black raspberries on azoxymethane-induced colon cancer and 8-hydroxy-2'-deoxyguanosine levels in the Fischer 344 rat. Nutr Cancer
  143. (1989). Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res
  144. (1998). Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Research
  145. (2003). Endosomal and lysosomal effects of desferrioxamine: Protection of HeLa cells from hydrogen peroxide-induced DNA damage and induction of cell-cycle arrest. Free Radical Biology and Medicine
  146. (1988). Environmental exposure N-aryl compounds.
  147. (1985). Environmental Health Perspectives
  148. (2008). Epidemiology and genetic susceptibility to bladder cancer. Bju International
  149. (1994). Epidemiology of Cancer from Exposure to Arylamines. Environmental Health Perspectives
  150. (2007). Epidemiology of urinary bladder cancer: from tumor development to patient's death.
  151. (2002). Epidermal growth factor receptor and bladder cancer.
  152. (2005). Establishing the background level of base oxidation in human lymphocyte DNA: results of an interlaboratory validation study. Faseb Journal
  153. (2008). Estimates of worldwide burden of cancer in 2008: GLOBOCAN
  154. (2000). Estimation of daily intake distribution of flavonols and flavanones in Denmark.
  155. (1998). Evidence that MutY is a monofunctional glycosylase capable of forming a covalent Schiff base intermediate with substrate DNA. Nucleic Acids Res
  156. (2006). Experimental models of human bladder carcinogenesis. Carcinogenesis
  157. (1995). Expression of C-Myc Protein Is Related to Cell-Proliferation and Expression of Growth-Factor Receptors in Transitional-Cell Bladder-Cancer.
  158. (1994). Expression of Epidermal Growth-Factor Receptor in Bladder-Cancer as Related to Established Prognostic Factors, Oncoprotein (C-Erbb-2, P53) Expression and Long-Term Prognosis.
  159. (2004). FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma. Cancer Research
  160. (2003). FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder. Cancer Research
  161. (2000). Flavonoids as antioxidants.
  162. (1997). Fluorescence analysis of the labile iron pool of mammalian cells. Analytical Biochemistry
  163. (2008). Formamidopyrimidines in DNA: Mechanisms of formation, repair, and biological effects. Free Radical Biology and Medicine
  164. (1985). Formation of an 8-Hydroxyguanine Moiety in Deoxyribonucleic-Acid on Gamma-Irradiation in Aqueous-Solution. Biochemistry
  165. (2000). Formation of N-nitrosamines and N-nitramines by the reaction of secondary amines with peroxynitrite and other reactive nitrogen species: Comparison with nitrotyrosine formation. Chemical Research in Toxicology
  166. (2006). Fragmentation of replicating chromosomes triggered by uracil in DNA.
  167. (2007). Free radical scavenging capacity and antioxidant enzyme activity
  168. (1989). Free Radicals in Biology and Medicine.
  169. (2003). Frequent hypermethylation of promoter region of RASSF1A in tumor tissues and voided urine of urinary bladder cancer patients.
  170. (2001). Gender- and smoking-related bladder cancer risk.
  171. (2009). Gene expression profiling reveals new protective roles for vitamin C in human skin cells. Free Radical Biology and Medicine
  172. Generation of reactive oxygen species by the mitochondrial electron transport chain.
  173. (2006). Genetic alterations in urothelial bladder carcinoma - An updated review. Cancer
  174. (2003). Genetic alterations of P16INK4A and P14ARF genes in human bladder cancer.
  175. (2006). Grabaric BS. A novel amperometric method for antioxidant activity determination using DPPH free radical. Bioelectrochemistry
  176. (1999). H-ferritin subunit overexpression in erythroid cells reduces the oxidative stress response and induces multidrug resistance properties. Blood
  177. (2003). Handbooks of Cancer Prevention. In: Fruits and Vegetables--Bianchini
  178. (2009). Health Statistic
  179. (1998). Hemin-enhanced resistance of human leukemia cells to oxidative killing: Antisense determination of ferritin involvement.
  180. (2002). HER2 overexpression in muscle-invasive urothelial carcinoma of the bladder: Prognostic implications.
  181. (2009). Heterocyclic aromatic amine intake increases colorectal adenoma risk: findings from a prospective European cohort study.
  182. (1990). Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the &quot;comet&quot; assay. Radiat Res
  183. (1999). High intake of specific carotenoids and flavonoids does not reduce the risk of bladder cancer. Nutr Cancer
  184. (2010). HO* radicals induce an unexpected high proportion of tandem base lesions refractory to repair by DNA glycosylases.
  185. (2006). hOGG1 recognizes oxidative damage using the comet assay with greater specificity than FPG or ENDOIII. Mutagenesis
  186. (1999). Human and Escherichia coli beta-glucuronidase hydrolysis of glucuronide conjugates of benzidine and 4-aminobiphenyl, and their hydroxy metabolites. Drug Metabolism and Disposition
  187. (2000). Hydrogen peroxide in the human body. Febs Letters
  188. (1998). Hydrogen peroxide-induced DNA damage is independent of nuclear calcium but dependent on redox-active ions.
  189. (1979). Hydroperoxide Metabolism in Mammalian Organs. Physiological Reviews
  190. (2004). Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer.
  191. (2003). Identification of fibroblast growth factor receptor 3 mutations in urine sediment DNA samples complements cytology in bladder tumor detection (vol 98, pg 44,
  192. (2002). Identification of N-(deoxyguanosin-8-yl)-4-azobiphenyl by P-32-postlabeling analyses of DNA in human uroepithelial cells exposed to proximate metabolites of the environmental carcinogen 4-aminobiphenyl. Environmental and Molecular Mutagenesis
  193. (2009). Improved Detection and Reduced Early Recurrence of NonMuscle-Invasive Bladder Cancer Using Hexaminolaevulinate Fluorescence Cystoscopy: Results of a Multicentre Prospective Randomized Study (Pc
  194. (2007). Improved production of caffeic acid derivatives in suspension cultures of Echinacea purpurea by medium replenishment strategy. Arch Pharm Res
  195. (2009). In vitro viability and cytotoxicity testing and same-well multiparametric combinations for high throughput screening. Curr Chem Genomics
  196. (2000). Incorporation of the elderberry anthocyanins by endothelial cells increases protection against oxidative stress. Free Radic Biol Med
  197. (1991). Increased formation of 8-hydroxy-2'-deoxyguanosine Ames BN, Gold LS. Endogenous Mutagens and the Causes of Aging and Cancer. Mutation Research
  198. (2003). Induction of apoptosis in cancer cells by Bilberry (Vaccinium myrtillus) and the anthocyanins. J Agric Food Chem
  199. (1995). Induction of Ferritin Synthesis by Oxidative Stress - Transcriptional and Posttranscriptional Regulation by Expansion of the Free Iron Pool.
  200. (1998). Influence of iron chelation on the antioxidant activity of flavonoids. Biochemical Pharmacology
  201. (1991). Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature
  202. (1993). Instability and Decay of the Primary Structure of DNA. Nature
  203. (1993). Intake of Potentially Anticarcinogenic Flavonoids and Their Determinants
  204. (1992). Intake of Vegetables, Fruits, BetaCarotene, Vitamin-C and Vitamin Supplements and Cancer Incidence among the Elderly - a Prospective-Study.
  205. (2004). Interventions with antioxidants and nutrients in relation to oxidative DNA damage and repair. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis
  206. (2007). Intracellular copper does not catalyze the formation of oxidative DNA damage in Escherichia coli.
  207. (2001). Intracellular iron, but not copper, plays a critical role in hydrogen peroxide-induced DNA Damage. Free Radical Biology and Medicine
  208. (2003). Intralysosomal iron: A major determinant of oxidant-induced cell death. Free Radical Biology and Medicine
  209. (2009). Introducing a true internal standard for the Comet assay to minimize intra- and inter-experiment variability in measures of DNA damage and repair.
  210. (2009). Introducing a true internal standard for the Comet assay to minimize intra- and inter-experiment variability in measures of DNA damage and repair. Nucleic Acids Res
  211. (1982). Invasive Bladder-Carcinoma Managed by Irradiation and Surgery. Urology
  212. (1995). Iron Acquired from Transferrin by K562 Cells Is Delivered into a Cytoplasmic Pool of Chelatable Iron(Ii).
  213. (2006). Iron chelation by the powerful antioxidant flavonoid quercetin.
  214. (1997). Iron homeostasis, oxidative stress, and DNA damage. Free Radical Biology and Medicine
  215. (1998). Iron in cytosolic ferritin can be recycled through lysosomal degradation in human fibroblasts.
  216. (1991). Iron Is the Intracellular Metal Involved in the Production of DNA Damage by Oxygen Radicals. Mutation Research
  217. (2006). Iron-chelation properties of phenolic acids bearing catechol and galloyl groups. Food Chemistry
  218. (2010). Isolation and free-radical-scavenging properties of cyanidin 3-O-glycosides from the fruits of Ribes biebersteinii Berl. Acta Pharmaceutica
  219. (1982). Isolation of Mutagenic Aromatic-Amines from a Coal Conversion Oil by Cation-Exchange Chromatography. Analytical Chemistry
  220. (2009). Key Concerns About the Current State of Bladder Cancer A Position Paper From the Bladder Cancer Think Tank, the Bladder Cancer Advocacy Network, and the Society of Urologic Oncology. Cancer
  221. (2008). Laboratory and clinical studies of cancer chemoprevention by antioxidants in berries. Carcinogenesis
  222. (1995). Lethal Hydrogen-Peroxide Toxicity Involves Lysosomal Iron-Catalyzed Reactions with Membrane Damage. Redox Report
  223. (2010). Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols. PLoS One
  224. (2003). Limited repair of 8-hydroxy-7,8-dihydroguanine residues in human testicular cells. Nucleic Acids Research
  225. (2006). Liquid chromatography-electrospray ionization-mass spectrometry: the future of DNA adduct detection. Carcinogenesis
  226. (1997). Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: A cooperative group study.
  227. (1997). Lysosomal heterogeneity between and within cells with respect to resistance against oxidative stress. Histochemical Journal
  228. (1994). Lysosomal iron accumulation in diabetic nephropathy. Ren Fail
  229. (2009). Measurement of oxidative DNA damage induced by mainstream cigarette smoke in cultured NCI-H292 human pulmonary carcinoma cells. Mutation Research-Genetic Toxicology and Environmental Mutagenesis
  230. (2003). Measurements using the alkaline comet assay predict bladder cancer cell radiosensitivity.
  231. (2001). Mechanism of oxidative DNA damage induced by carcinogenic 4-aminobiphenyl. Free Radical Biology and Medicine
  232. (1999). Mechanisms of action of antioxidants as exemplified in vegetables, tomatoes and tea. Food and Chemical Toxicology
  233. (1994). Megadose vitamins in bladder cancer: a double-blind clinical trial.
  234. (2006). Membrane transport of hydrogen peroxide.
  235. (1992). Metabolism and Nucleic-Acid Binding of N-Hydroxy-4-Acetylaminobiphenyl and N-Acetoxy-4-Acetylaminobiphenyl by Cultured Human Uroepithelial Cells. Cancer Research
  236. (2005). Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: Identification of biomarkers and individual variability.
  237. (2002). Metabolism of N-acetylbenzidine and initiation of bladder cancer. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis
  238. (1984). Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells. Biochem Biophys Res Commun
  239. (1993). Migration patterns and breast cancer risk in Asian-American women.
  240. (1980). Mitochondrial Iron Not Bound in Heme and Iron-Sulfur Centers - Estimation, Compartmentation and Redox State. Biochimica Et Biophysica Acta
  241. (2002). MJaTL. Culture of Human Urothelium. In: Culture of Epithelial Cells--Freshney
  242. (2006). Molecular biology of bladder cancer: prognostic and clinical implications. Clin Genitourin Cancer
  243. (1999). Molecular determinants of outcome in bladder cancer.
  244. (1998). Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res
  245. (2008). Molecular markers in transitional cell carcinoma of the bladder: New insights into mechanisms and prognosis.
  246. (2004). Molecular Mechanisms Behind the Chemopreventive Effects of Anthocyanidins.
  247. (2001). Molecular mechanisms of iron uptake in eukaryotes.
  248. (2006). Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese? Carcinogenesis
  249. (2008). Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy. Cancer
  250. (1992). Mutagenic Specificity of Oxygen Radicals Produced by Human LeukemiaCells. Cancer Research
  251. (1995). Mutagenicity of a Unique 8-Oxoguanine in a Human Ha-Ras Sequence in Mammalian-Cells. Carcinogenesis
  252. (2004). Nature Reviews Molecular Cell Biology
  253. (1988). New York: Elsevier. Schumacker PT. Reactive oxygen species in cancer cells: Live by the sword, die by the sword.
  254. (2005). Novel mechanisms of natural antioxidant compounds in biological systems: Involvement of glutathione and glutathione-related enzymes.
  255. (2001). Novel methods for assessing transport of iron across biological membranes. In: Iron transport--Templeton
  256. (2000). Novel substrates of Escherichia coli Nth protein and its kinetics for excision of modified bases from DNA damaged by free radicals. Biochemistry
  257. (1993). Nuclear Overexpression of P53-Protein in Transitional Cell BladderCarcinoma - a Marker for Disease Progression.
  258. (2000). Nutrition - Antioxidant activity of fresh apples.
  259. (1995). nutrition, and avoidable cancer. Environmental Health Perspectives
  260. (2008). nutrition, physical activity and cancer prevention. Authoritative report from World Cancer Research Fund provides global update. Public Health Nutr
  261. (2003). Nutritional modulation of DNA repair in a human intervention study. Carcinogenesis
  262. (2002). obesity, and cancer risk. Lancet Oncol
  263. (1972). Occupation and Cancer of Lower Urinary-Tract. Cancer
  264. (2000). Overexpression of wild type and mutated human ferritin H-chain in HeLa cells - In vivo role of ferritin ferroxidase activity.
  265. (1992). Oxidative Damage to DNA in Mammalian Chromatin. Mutation Research
  266. (1996). Oxidative Damage to DNA: Do We Have a Reliable Biomarker? Environmental Health Perspectives
  267. (2003). Oxidative damage to DNA: formation, measurement and biochemical features. Mutation Research
  268. (2002). Oxidative DNA Damage Induced by a Metabolite of 2-Naphthylamine, a Smoking-related Bladder Carcinogen.
  269. (1997). Oxygen radical absorbing capacity of anthocyanins.
  270. (2000). Oxyradicals and DNA damage. Carcinogenesis
  271. (2006). p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer. Biochem Biophys Res Commun
  272. p53 immunohistochemistry as a prognostic marker in bladder cancer - Playground for urology scientists?
  273. (1995). P53 Immunohistochemistry as Am Independent Prognostic Factor for Superficial Transitional-Cell Carcinoma of the Bladder.
  274. (1994). P53 Mutations in Human Bladder-Cancer - Genotypic Versus Phenotypic Patterns.
  275. (2006). Pantuck AJ. Prevention of Bladder Cancer: A Review. European Urology
  276. (1977). Parasites in Etiology of Cancer - Bilharziasis and Bladder Cancer. Ca-a Cancer Journal for Clinicians
  277. (2001). Peroxynitrite scavenging of flavonoids: structure activity relationship. Environmental Toxicology and Pharmacology
  278. (2011). Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer.
  279. (2008). Phase III prevention trial of Fenretinide in patients with resected non-muscleinvasive bladder cancer. Clinical Cancer Research
  280. (1992). Phenolic Antioxidants. Critical Reviews in Food Science and Nutrition
  281. (2005). Phenolic composition and antioxidant activities in flesh and achenes of strawberries (Fragaria ananassa).
  282. (2005). Phenolic compounds from blueberries can inhibit colon cancer cell proliferation and induce apoptosis. J Agric Food Chem
  283. (2000). Plant-derived phenolic antioxidants. Current Opinion in Lipidology
  284. (1994). Polycyclic Aromatic Compounds
  285. (1993). Possible mechanisms of alteration in the capacities of carcinogen metabolizing enzymes during schistosomiasis and their role in bladder cancer induction.
  286. (1995). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.
  287. (2003). Prevention of oxidant-induced cell death by lysosomotropic iron chelators. Free Radical Biology and Medicine
  288. (1991). Production of Large Amounts of Hydrogen-Peroxide by Human Tumor-Cells. Cancer Research
  289. (1982). Prognostic Parameters in Superficial Bladder-Cancer - an Analysis of 315 Cases.
  290. (1995). Progression of Subcellular Changes during Chemical Hypoxia to Cultured Rat Hepatocytes - a LaserScanning Confocal Microscopic Study. Hepatology
  291. (2005). Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.
  292. (2003). Protection against ionizing radiation by antioxidant nutrients and phytochemicals. Toxicology
  293. (2005). Protection against nuclear DNA damage offered by flavonoids in cells exposed to hydrogen peroxide: The role of iron chelation. Free Radical Biology and Medicine
  294. (2005). Protection by quercetin and quercetinrich fruit juice against induction of oxidative DNA damage and formation of BPDEDNA adducts in human lymphocytes. Mutation Research-Genetic Toxicology and Environmental Mutagenesis
  295. (2005). Protection by tropolones against H2O2-induced DNA damage and apoptosis in cultured Jurkat cells. Free Radical Research
  296. (2010). Protection of cells in physiological oxygen tensions against DNA damage-induced apoptosis.
  297. (2008). Protective Effect of Anthocyanins from Black Soybean Seed Coats on UVBInduced Apoptotic Cell Death in Vitro and in Vivo.
  298. (2010). Protective Effects of Bilberry (Vaccinium myrtillus L.) Extract against Endotoxin-Induced Uveitis in Mice.
  299. (2008). Protective effects of extracts of Vernonia amygdalina, Hibiscus sabdariffa and vitamin C against radiation-induced liver damage in rats.
  300. (1995). Pyridoxine (Vitamin-B-6) and Their Influence on the Recurrence Rate of Superficial Bladder-Cancer. European Urology
  301. (1997). Quantitation of 8-oxoguanine and strand breaks produced by four oxidizing agents. Chemical Research in Toxicology
  302. (1987). Radiation and hydrogen peroxide induced free radical damage to DNA.
  303. (2009). Radiation cystitis.
  304. (2005). Radiation-induced damage to cellular DNA: measurement and biological role. Radiation Physics and Chemistry
  305. (1988). Radical Biology and Medicine
  306. (1994). Radioprotective Effect of Antioxidative Flavonoids in Gamma-Ray Irradiated Mice. Carcinogenesis
  307. (2000). Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end point. Cancer Epidemiol Biomarkers Prev
  308. (1983). Rapid Colorimetric Assay for Cellular Growth and Survival - Application to Proliferation and Cyto-Toxicity Assays.
  309. (1994). Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol Biomarkers Prev
  310. (2010). Rapid method for determination of DNA repair capacity in human peripheral blood lymphocytes amongst smokers.
  311. (2003). Recommendations for conducting the in vivo alkaline Comet assay.
  312. (2000). Reduction in free-radicalinduced DNA strand breaks and base damage through fast chemical repair by flavonoids. Free Radical Research
  313. (1995). Relationship between Free Iron Level and Rat-Liver Mitochondrial Dysfunction in Experimental Dietary Iron Overload. Biochemical and Biophysical Research Communications
  314. (1999). Relationship between schistosomiasis and bladder cancer. Clinical Microbiology Reviews
  315. (2004). Relocalized redox-active lysosomal iron is an important mediator of oxidative-stress-induced DNA damage.
  316. (1999). Repair of oxidative DNA base lesions induced by fluorescent light is defective in xeroderma pigmentosum group A cells. Nucleic Acids Research
  317. (2002). Repair of oxidative DNA damage: assessing its contribution to cancer prevention. Mutagenesis
  318. (2001). Repression of ferritin expression increases the labile iron pool, oxidative stress, and short-term growth of human erythroleukemia cells. Blood
  319. (2008). Response of cell cycle/stress-related protein expression and DNA damage upon treatment of CaCo2 cells with anthocyanins.
  320. (2003). Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem Biophys Res Commun
  321. (1995). Retinoblastoma Gene-Mutations in Primary Human Bladder-Cancer.
  322. (2004). Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries. Lancet
  323. (2005). Role of compartmentalized redoxactive iron in hydrogen peroxide-induced DNA damage and apoptosis.
  324. Role of PPAR gamma and EGFR signalling in the urothelial terminal differentiation programme.
  325. (2001). Role of TP53 in repair of N(deoxyguanosin-8-yl)-4-aminobiphenyl adducts in human transitional cell carcinoma of the urinary bladder. Carcinogenesis
  326. (2000). Scavenging capacity of berry crops on superoxide radicals, hydrogen peroxide, hydroxyl radicals, and singlet oxygen.
  327. (1987). Second edition edn.
  328. (2001). Sensitive determination of cell number using the CyQUANT cell proliferation assay.
  329. (2004). Sensitivity and variability of visual scoring in the comet assay. Results of an inter-laboratory scoring exercise with the use of silver staining. Mutat Res
  330. (2004). Sensitivity of the FPG protein towards alkylation damage in the comet assay. Toxicology Letters
  331. (2002). Signaling networks that link cell proliferation and cell fate.
  332. (1999). Single cell gel electrophoresis assay: methodology and applications.
  333. (2000). Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen
  334. (2001). Single-strand interruptions in replicating chromosomes cause double-strand breaks.
  335. (1993). Single-Stranded Shuttle Phagemid for Mutagenesis Studies in Mammalian-Cells -
  336. (2009). SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer.
  337. (2006). Smoking and bladder cancer in Spain: Effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiology Biomarkers & Prevention
  338. (1991). Smoking Related Carcinogen DNA Adducts in Biopsy Samples of Human Urinary-Bladder - Identification of N-(Deoxyguanosin-8-Yl)-4-Aminobiphenyl as a Major Adduct.
  339. (2002). Spectroscopic and structural study of complexes of quercetin with Al(III).
  340. (2004). Squamous cell carcinoma of the bladder: pathology, diagnosis and treatment. Bju International
  341. (2005). Stability of ferric complexes with 3-hydroxyflavone (flavonol), 5,7-dihydroxyflavone (chrysin), and 3 ',4 '-dihydroxyflavone.
  342. (2008). Staging, Grading, and Risk Stratification of Bladder Cancer. European Urology Supplements
  343. (2009). Statistical analysis of comet assay data. In: The comet assay in toxicology--Dhawan AaA,
  344. (1996). Structural aspects of antioxidant activity of flavonoids. Free Radical Biology and Medicine
  345. (1998). Structural dependence of flavonoid interactions with Cu2+ ions: implications for their antioxidant properties.
  346. (2002). Structure activity relationship of natural flavonoids in hydroxyl radical-scavenging effects. Acta Phamacol Sin
  347. (1996). Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biology and Medicine
  348. (2002). Structure-antioxidant activity relationships of flavonoids: A re-examination. Free Radical Research
  349. (2008). Structure-Function Relationships of Anthocyanins from Various Anthocyanin-Rich Extracts on the Inhibition of Colon Cancer Cell Growth.
  350. (2006). Structure-radical scavenging activity relationships of flavonoids. Phytochemistry
  351. (2001). Subcellular distribution of chelatable iron: a laser scanning microscopic study in isolated hepatocytes and liver endothelial cells.
  352. (2007). Substrate specificity of fpg (MutM) and hOGG1, two repair glycosylases.
  353. (1994). Substrate-Specificity of Fpg Protein - Recognition and Cleavage of Oxidatively Damaged DNA.
  354. (1974). Superoxide Radicals as Precursors of Mitochondrial Hydrogen-Peroxide. Febs Letters
  355. (1991). Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res
  356. (2002). The biochemistry and medical significance of the flavonoids. Pharmacology and Therapeutics
  357. (1987). The chemical basis of radiation biology
  358. (2004). The Comet Assay for DNA Damage and Repair: Principles, Applications, and Limitations. Molecular Biotechnology
  359. (1996). The comet assay: Mechanisms and technical considerations. Mutation Research-DNA Repair
  360. (2008). The comet assay: topical issues. Mutagenesis
  361. (1997). The comet assay: what can it really tell us? Mutation Research
  362. (1988). The decline in cancer mortality in the European Union,
  363. (1991). The E2f Transcription Factor Is a Cellular Target for the Rb Protein. Cell
  364. (2005). The economic consequences of prostate and bladder cancer in the UK. Bju International
  365. (2001). The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate. Cancer Research
  366. (1976). The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet.
  367. (2003). The health economics of bladder cancer - A comprehensive review of the published literature. Pharmacoeconomics
  368. (2011). The Impact of Chemoprevention on Treatment Regimens for Non-Muscle Invasive Bladder Cancer. In:
  369. (1997). The influence of cell growth, detoxifying enzymes and DNA repair on hydrogen peroxide-mediated DNA damage (measured using the comet assay) in human cells. Free Radical Biology and Medicine
  370. (1995). The kinetics of repair of oxidative DNA damage (strand breaks and oxidised pyrimidines) in human cells. Mutation Research
  371. (2002). The labile iron pool: Characterization, measurement, and participation in cellular processes. Free Radical Biology and Medicine
  372. (2002). The level of 8-oxo-7,8-dihydro-2 '-deoxyguanosine is positively correlated with the size of the labile iron pool in human lymphocytes.
  373. (1994). The liver and iron. In: The Liver: Biology and Pathobiology --Arias
  374. (1992). The Measurement of Oxidative Damage to DNA by Hplc and Gc/Ms Techniques. Free Radical Research Communications
  375. (1998). The nature and origin of DNA single-strand breaks determined with the comet assay. Mutation Research
  376. (2005). The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling. Biochemistry and Cell Biology-Biochimie Et Biologie Cellulaire
  377. (2002). The role of metals in site-specific DNA damage with reference to carcinogenesis. Free Radical Biology and Medicine
  378. (1986). Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines. Cancer Res
  379. (1989). Tobacco and Bladder-Cancer in Males -Increased Risk for Inhalers and Smokers of Black Tobacco.
  380. (2004). Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of carcinogenicrisks to humans
  381. (1999). Tobacco smoke carcinogens and lung cancer.
  382. (1988). Toxic DNA Damage by Hydrogen-Peroxide through the Fenton Reaction Invivo and Invitro. Science
  383. (2002). Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development. Clinical Cancer Research
  384. (2001). Two genetic hits (more or less) to cancer. Nature Reviews Cancer
  385. (1999). Undetectable intracellular free copper: The requirement of a copper chaperone for superoxide dismutase. Science
  386. (2009). Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience. Urology
  387. (1990). Urothelial Cancer and Some Industry-Related Chemicals - an Evaluation of the Epidemiologic Literature.
  388. (2005). Urothelial tumorigenesis: A tale of divergent pathways. Nature Reviews Cancer
  389. (1999). Urothelium-specific expression of an oncogene in transgenic. mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma. Cancer Research
  390. (2008). Use of DNA adducts to identify human health risk from exposure to hazardous environmental pollutants: the increasing role of mass spectrometry in assessing biologically effective doses of genotoxic carcinogens. Mutat Res
  391. (1992). Using Hydroxyl Radical to Probe DNA-Structure. Methods in Enzymology
  392. (2002). Variation and heritability estimates for antioxidant activity, total phenolic content, and anthocyanin content in blueberry progenies.
  393. (2010). Variation in the measurement of DNA damage by comet assay measured by the ECVAG inter-laboratory validation trial. Mutagenesis
  394. (1992). vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer
  395. (2007). Vitamin C modulation of H2O2-induced damage and iron homeostasis in human cells. Free Radical Biology and Medicine
  396. (1993). Waf1, a Potential Mediator of P53 Tumor Suppression. Cell
  397. (2004). WHO mortality data base,

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.